Compounds > abt 702
Page last updated: 2024-10-21

abt 702 and Neuroretinitis

abt 702 has been researched along with Neuroretinitis in 1 studies

Research Excerpts

ExcerptRelevanceReference
"This study was undertaken to determine the effect of an adenosine kinase inhibitor (AKI) in diabetic retinopathy (DR)."7.79ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy. ( Ahmad, S; Al-Gayyar, MM; Eissa, LA; El-Shishtawy, MM; Elsherbini, AM; Elsherbiny, NM; Fulzele, S; Liou, GI; Naime, M, 2013)
"This study was undertaken to determine the effect of an adenosine kinase inhibitor (AKI) in diabetic retinopathy (DR)."3.79ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy. ( Ahmad, S; Al-Gayyar, MM; Eissa, LA; El-Shishtawy, MM; Elsherbini, AM; Elsherbiny, NM; Fulzele, S; Liou, GI; Naime, M, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elsherbiny, NM1
Ahmad, S1
Naime, M1
Elsherbini, AM1
Fulzele, S1
Al-Gayyar, MM1
Eissa, LA1
El-Shishtawy, MM1
Liou, GI1

Other Studies

1 other study available for abt 702 and Neuroretinitis

ArticleYear
ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy.
    Life sciences, 2013, Jul-30, Volume: 93, Issue:2-3

    Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adenosine Kinase; Animals; Cells, Cultured; Diabetes M

2013